FDA — authorised 7 December 2001
- Application: NDA021345
- Marketing authorisation holder: MYLAN IRELAND LTD
- Status: supplemented
FDA authorised Arixtra on 7 December 2001
Yes. FDA authorised it on 7 December 2001; FDA has authorised it.
MYLAN IRELAND LTD holds the US marketing authorisation.